investordatabase.org

Remora Biotech SA

remora-biotech.ch Direct investor

Remora Biotech builds and develops biotherapy companies from academic science, taking them through design, proof-of-concept and sale to strategic partners. It also holds strategic minority investments in biotech companies.

Remora Biotech SA is a venture studio headquartered in Epalinges, Switzerland. It invests directly in companies, in regenerative & Aesthetics, immunotherapy, vectorized and cell & Gene Therapy.

“We combine scientific excellence with entrepreneurial execution to advance a diversified portfolio of biotherapy companies.”

— Remora Biotech SA, own website
Layer
Direct investor
Type
Venture studio
Stage
Not stated
Headquarters
Epalinges, Switzerland
Sectors
Regenerative & Aesthetics, Immunotherapy, Vectorized, Cell & Gene Therapy

Team, as Remora Biotech SA publishes it

  • Dr. Jean-Marc Le Doussal, MBA Founder & Chief Executive Officer
  • Dr. David Béchard Chief Executive Officer France
  • Hervé Cathelin Chairman of the Board
  • Dr. Charles Woler Board Member
  • Richard Groenendijk Chief Finance Officer
  • Dr. Jérôme Jaquier General Counsel
  • Florian Le Thoer Chief Corporate Development Officer
  • Dean Slagel Head of Strategic Partnerships
  • Albert Wagner Chief Accounting Officer
  • Prof. Denis Migliorini, MD Cell & Gene Therapy Co-Founder

Names and roles exactly as listed on remora-biotech.ch. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Remora Biotech SA publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 16456 · added 2026-10-26 · link last verified 2026-10-26 · confidence medium

Similar investors

Listed under